Institutional investors control 39.35% of the outstanding shares in HPTX. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended March 2013, these large investors purchased a net $5.1 million shares.
| Individual stakeholders | 54.58% |
| Other institutional | 25.85% |
| Mutual fund holders | 13.51% |